Table 3.
Abnormal laboratory results in two groups of COVID-19 patients
| Characteristics | Non-elderly patients | Elderly patients | P value |
|---|---|---|---|
| Leucocytes (× 109 per L; normal range 3.5–9.5) | 0.584 | ||
| Increased | 7 (15.6%) | 3 (13.0%) | |
| Decreased | 4 (8.9%) | 4 (17.4%) | |
| Neutrophils (× 109 per L; normal range 2–7) | 0.961 | ||
| Increased | 7 (15.6%) | 3 (13.0%) | |
| Lymphocytes (× 109 per L; normal range 0.8–4) | 0.422 | ||
| Decreased | 14 (31.1%) | 10 (43.5%) | |
| CD3 Count (cells/ul; normal range 770–2041) | 0.114 | ||
| Decreased | 26 (57.8%) | 18 (78.3%) | |
| CD4 Count (cells/ul; normal range 414–1123) | 0.065 | ||
| Decreased | 24 (53.3%) | 18 (78.3%) | |
| CD8 Count (cells/ul; normal range 238–874) | 0.009 | ||
| Decreased | 22 (48.9%) | 19 (82.6%) | |
| B Count (cells/ul; normal range 90–560) | 0.036 | ||
| Decreased | 13 (44.8%) | 14 (77.8%) | |
| NK Count (cells/ul; normal range 150–1100) | 1.000 | ||
| Decreased | 21 (72.4%) | 13 (72.2%) | |
| C-reactive protein (mg/L; normal range 0–5) | 0.389 | ||
| Increased | 32 (71.1%) | 18 (81.8%) | |
| Alanine aminotransferase (U/L; normal range 0–37) | 0.067 | ||
| Increased | 14 (31.1%) | 2 (9.1%) | |
| Aspartate aminotransferase (U/L; normal range 0–37) | 0.745 | ||
| Increased | 8 (17.8%) | 5 (22.7%) | |
| Albumin (g/L; normal range 35–55) | 0.052 | ||
| Decreased | 6 (13.3%) | 8 (36.4%) | |
| Lactic dehydrogenase | 0.594 | ||
| Increased | 16 (35.6%) | 10 (45.5%) | |
| Hydroxybutyrate Dehydrogenase | 0.193 | ||
| Increased | 18 (40.0%) | 13 (59.1%) | |
| Creatine jubase | 0.745 | ||
| Increased | 8 (17.8%) | 5 (22.7%) |